Results 41 to 50 of about 90,536 (296)

Building the economic evidence case for social prescribing [PDF]

open access: yes, 2023
Understanding the economic impact of social prescribing remains an urgent priority for the National Academy of Social Prescribing (NASP). As yet it is unclear how much data exists within the different systems to enable economic analyses of the impact of ...
Seers, H.   +6 more
core  

iSIMPATHY: a multinational pre–post non-randomised intervention study transforming medication review

open access: yesBMJ Open
Background Taking multiple medicines can be appropriate but has the potential to be problematic. The Implementing Stimulating Innovation in the Management of Polypharmacy and Adherence THrough the Years (iSIMPATHY) project used the 7-Steps person-centred
Michael G Scott   +10 more
doaj   +1 more source

‘Doing the right thing’: factors influencing GP prescribing of antidepressants and prescribed doses

open access: yesBMC Family Practice, 2017
Background Antidepressant prescribing continues to increase, with 5-16% of adults receiving antidepressants annually. Total prescribing growth is due in part to increased long-term use, greater selective serotonin re-uptake inhibitor (SSRI) use and the ...
Chris F. Johnson   +4 more
doaj   +1 more source

Applying critical systems thinking to social prescribing: a relational model of stakeholder “buy-in” [PDF]

open access: yes, 2020
Background Social prescribing (SP) allows health professionals to refer primary care patients toward health and wellbeing interventions and activities in the local community.
Fixsen, Alison, Polley, M.J., Seers, H.
core   +1 more source

Speaking the Same Language – The Development of a Glossary of Terms for Social Prescribing in Wales

open access: yesInternational Journal of Integrated Care
Introduction: Social prescribing can facilitate the integration of health, social care and community support but has a diverse and confusing terminology that impairs cross-sectoral communication and creates barriers to engagement.
Simon Newstead   +5 more
doaj   +1 more source

Social prescribing for people with complex needs: a realist evaluation

open access: yesBMC Family Practice, 2021
Background Social Prescribing is increasingly popular, and several evaluations have shown positive results. However, Social Prescribing is an umbrella term that covers many different interventions.
Emily Wood   +4 more
doaj   +1 more source

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

open access: yesFEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Prescribing by mental health nurses: the UK perspective

open access: yes, 2009
PURPOSE. This article aims to discuss the growth of mental health nurse (MHN) prescribing in the United Kingdom as an exemplar for readers to compare progress in their own countries and context.
Hemingway, Steve, Ely, Val, Ely, Valerie
core   +1 more source

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen   +11 more
wiley   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

open access: yesAging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy